CA2469599C - Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof - Google Patents

Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof Download PDF

Info

Publication number
CA2469599C
CA2469599C CA2469599A CA2469599A CA2469599C CA 2469599 C CA2469599 C CA 2469599C CA 2469599 A CA2469599 A CA 2469599A CA 2469599 A CA2469599 A CA 2469599A CA 2469599 C CA2469599 C CA 2469599C
Authority
CA
Canada
Prior art keywords
pcv2
chimeric
pcv1
dna
pigs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2469599A
Other languages
English (en)
French (fr)
Other versions
CA2469599A1 (en
Inventor
Xiang-Jin Meng
Martijn Fenaux
Patrick G. Halbur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Tech Intellectual Properties Inc
Iowa State University Research Foundation Inc
Original Assignee
Virginia Tech Intellectual Properties Inc
Iowa State University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intellectual Properties Inc, Iowa State University Research Foundation Inc filed Critical Virginia Tech Intellectual Properties Inc
Priority to CA2784260A priority Critical patent/CA2784260C/en
Publication of CA2469599A1 publication Critical patent/CA2469599A1/en
Application granted granted Critical
Publication of CA2469599C publication Critical patent/CA2469599C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2469599A 2001-12-12 2002-12-11 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof Expired - Lifetime CA2469599C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2784260A CA2784260C (en) 2001-12-12 2002-12-11 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US34077501P 2001-12-12 2001-12-12
US60/340,775 2001-12-12
US42484002P 2002-11-08 2002-11-08
US60/424,840 2002-11-08
US10/314,512 US7276353B2 (en) 2001-12-12 2002-12-09 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US10/314,512 2002-12-09
PCT/US2002/039646 WO2003049703A2 (en) 2001-12-12 2002-12-11 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2784260A Division CA2784260C (en) 2001-12-12 2002-12-11 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof

Publications (2)

Publication Number Publication Date
CA2469599A1 CA2469599A1 (en) 2003-06-19
CA2469599C true CA2469599C (en) 2012-10-23

Family

ID=27405726

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2469599A Expired - Lifetime CA2469599C (en) 2001-12-12 2002-12-11 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
CA2784260A Expired - Lifetime CA2784260C (en) 2001-12-12 2002-12-11 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2784260A Expired - Lifetime CA2784260C (en) 2001-12-12 2002-12-11 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof

Country Status (30)

Country Link
US (1) US7276353B2 (cg-RX-API-DMAC7.html)
EP (5) EP3388515A1 (cg-RX-API-DMAC7.html)
JP (1) JP4623964B2 (cg-RX-API-DMAC7.html)
KR (1) KR101014544B1 (cg-RX-API-DMAC7.html)
CN (2) CN103536911B (cg-RX-API-DMAC7.html)
AT (1) ATE487490T1 (cg-RX-API-DMAC7.html)
AU (3) AU2002362147C1 (cg-RX-API-DMAC7.html)
BE (1) BE2011C008I2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0214919B1 (cg-RX-API-DMAC7.html)
CA (2) CA2469599C (cg-RX-API-DMAC7.html)
CO (1) CO5590938A2 (cg-RX-API-DMAC7.html)
CY (3) CY1111167T1 (cg-RX-API-DMAC7.html)
DE (2) DE60238278D1 (cg-RX-API-DMAC7.html)
DK (3) DK2264050T3 (cg-RX-API-DMAC7.html)
ES (3) ES2355814T3 (cg-RX-API-DMAC7.html)
FR (1) FR11C0014I2 (cg-RX-API-DMAC7.html)
HR (3) HRP20140002B1 (cg-RX-API-DMAC7.html)
HU (5) HU231162B1 (cg-RX-API-DMAC7.html)
LT (1) LT2264050T (cg-RX-API-DMAC7.html)
LU (1) LU91814I2 (cg-RX-API-DMAC7.html)
ME (1) ME00126B (cg-RX-API-DMAC7.html)
MX (1) MXPA04005364A (cg-RX-API-DMAC7.html)
NL (1) NL300480I2 (cg-RX-API-DMAC7.html)
NZ (2) NZ567688A (cg-RX-API-DMAC7.html)
PL (3) PL395510A1 (cg-RX-API-DMAC7.html)
PT (3) PT1487483E (cg-RX-API-DMAC7.html)
RS (1) RS51288B (cg-RX-API-DMAC7.html)
SI (3) SI2264050T1 (cg-RX-API-DMAC7.html)
TW (1) TWI314580B (cg-RX-API-DMAC7.html)
WO (1) WO2003049703A2 (cg-RX-API-DMAC7.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CN1749397B (zh) * 2004-08-18 2010-12-08 金宁一 共表达猪圆环病毒及口蹄疫病毒的二联重组活载体疫苗
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
RU2620968C9 (ru) 2004-12-30 2017-08-08 Берингер Ингельгейм Ветмедика, Инк. Иммуногенные композиции pcv2 и способы получения таких композиций
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
CN1328373C (zh) * 2005-04-07 2007-07-25 南京农业大学 猪ⅱ型圆环病毒重组腺病毒
EP1896069B1 (en) * 2005-06-24 2013-03-13 Intervet International BV Inactivated chimeric vaccines and related methods of use
CN101277717A (zh) 2005-09-09 2008-10-01 英特威国际有限公司 Pcv-2疫苗
CA2635430A1 (en) * 2005-12-29 2007-08-23 Boehringer Ingelheim Vetmedica, Inc. Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
DK2275132T3 (da) 2005-12-29 2021-05-17 Boehringer Ingelheim Animal Health Usa Inc Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille dem
JP4625485B2 (ja) * 2006-09-29 2011-02-02 財団法人大阪産業振興機構 高病原性トリインフルエンザウイルスに対するモノクローナル抗体
WO2008064299A2 (en) * 2006-11-22 2008-05-29 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
WO2008073464A2 (en) 2006-12-11 2008-06-19 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PT2094872T (pt) 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
EP1941903A1 (en) * 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
AU2008294036A1 (en) * 2007-05-30 2009-03-05 Wyeth Llc Raccoon poxvirus expressing genes of porcine virus
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
US9056909B2 (en) * 2007-11-06 2015-06-16 Zoetis Services Llc Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
CA2710247C (en) * 2007-12-21 2014-02-18 Wyeth Llc Methods and compositions for immunizing pigs against porcine circovirus
CN101932336B (zh) * 2007-12-31 2014-07-09 贝林格尔.英格海姆维特梅迪卡有限公司 有外来氨基酸插入的pcv2 orf2病毒样颗粒
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Pcv2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
EP2254595A4 (en) * 2008-02-15 2012-12-05 Boehringer Ingelheim Vetmed METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES
KR20100135903A (ko) * 2008-04-16 2010-12-27 버지니아 테크 인터렉추얼 프라퍼티스, 인크. 키메라 돼지 써코바이러스 PCV2Gen―1Rep 및 이의 용도
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
HUE047972T2 (hu) 2010-03-16 2020-05-28 Virginia Tech Intellectual Properties Inc Gyengített, élõ kiméra sertés cirkovírus vakcina
TWI508974B (zh) 2010-12-22 2015-11-21 Sbc Virbac Ltd 豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用
US20130313127A1 (en) 2010-12-28 2013-11-28 The University Of Tokyo Organic compound hydrogenation device and hydrogenation method
HUP1100470A2 (en) * 2011-08-30 2013-03-28 Mezoegazdasagi Biotechnologiai Kutatokoezpont Nanoparticle-based veterinary vaccine
UA113192C2 (xx) 2011-12-06 2016-12-26 Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
KR102217387B1 (ko) * 2013-03-11 2021-02-19 주식회사 중앙백신연구소 재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
CA2925281C (en) 2013-09-25 2022-05-03 Zoetis Services Llc Pcv2b divergent vaccine composition and methods of use
ES2778425T3 (es) 2013-10-02 2020-08-10 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta
CN103602759B (zh) * 2013-11-22 2015-09-23 福建省农业科学院畜牧兽医研究所 一种区别鸭圆环病毒和鹅圆环病毒的pcr-rflp方法
PL3076996T3 (pl) 2013-12-03 2020-05-18 Intervet International B.V. Szczepionka przeciwko cirkowirusowi świń typu 2
MX2018010796A (es) * 2016-03-07 2019-01-14 Virginia Tech Intellectual Properties Inc Vacunas de circovirus porcino quimerico tipo 2 (pcv2).
CN106497892A (zh) * 2016-09-07 2017-03-15 扬州大学 带KT3标签的重组病毒rPCV2‑KT3的构建方法
CN119488586A (zh) 2018-03-26 2025-02-21 勃林格殷格翰动物保健美国有限公司 制备免疫原性组合物的方法
CN112898435B (zh) * 2021-01-14 2023-03-31 山西农业大学 一种可溶性融合蛋白DT390-Cap及其制备方法与应用
AR132582A1 (es) 2023-05-03 2025-07-16 Boehringer Ingelheim Vetmedica Gmbh Método para inducir una respuesta inmunitaria
EP4704977A1 (en) 2023-05-03 2026-03-11 Boehringer Ingelheim Vetmedica GmbH Immunogenic composition useful for self-administration by pigs
US20250332242A1 (en) 2024-04-30 2025-10-30 Zoetis Services Llc Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use
US20250332243A1 (en) 2024-04-30 2025-10-30 Zoetis Services Llc Methods of manufacturing porcine endogenous retrovirus (perv) free animal health vaccines
WO2026099754A1 (en) 2024-11-06 2026-05-15 Boehringer Ingelheim Vetmedica Gmbh Method for reducing virus shedding, tissue colonization, and lymphoid depletion caused by or associated with pcv2 infection

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US6391314B1 (en) * 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
FR2769321B1 (fr) 1997-10-03 2001-10-26 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2769322B1 (fr) 1997-10-03 2002-03-08 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
JP3795751B2 (ja) * 1997-12-11 2006-07-12 ユニバーシティ オブ サスカッチェワン ブタからの離乳後多全身系消耗症候群ウイルス
WO1999045956A1 (en) 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
US6497883B1 (en) * 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
WO2001083737A2 (en) 2000-05-03 2001-11-08 University Of Guelph Porcine adenovirus type 5 vector and vaccine
JP2003533989A (ja) * 2000-05-24 2003-11-18 メリアル ブタ生殖・呼吸症候群ウィルス(prrsv)の組換えポックスウィルスワクチン
WO2001096377A2 (en) 2000-06-15 2001-12-20 Purdue Research Foundation Vaccine for congenital tremors in pigs
DE10044648A1 (de) * 2000-09-08 2002-03-21 Aventis Behring Gmbh Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
MY146518A (en) * 2001-03-27 2012-08-15 Univ Saskatchewan Methods to culture circovirus.
AUPR567401A0 (en) 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines

Also Published As

Publication number Publication date
ES2694505T3 (es) 2018-12-21
MXPA04005364A (es) 2004-09-27
EP2264050B1 (en) 2018-08-08
CN103536911A (zh) 2014-01-29
PL214803B1 (pl) 2013-09-30
WO2003049703A8 (en) 2005-12-01
DE122011100001I1 (de) 2011-09-08
NZ567688A (en) 2009-09-25
HUP0501000A2 (en) 2007-12-28
TW200307042A (en) 2003-12-01
HRP20040626A2 (en) 2006-03-31
EP1487483B1 (en) 2010-11-10
CA2784260C (en) 2016-05-17
PL395510A1 (pl) 2011-12-19
HUP1300097A2 (en) 2007-12-28
WO2003049703A3 (en) 2004-09-30
FR11C0014I2 (fr) 2022-03-11
KR101014544B1 (ko) 2011-02-16
BE2011C008I2 (cg-RX-API-DMAC7.html) 2022-02-02
WO2003049703A2 (en) 2003-06-19
EP2263690A3 (en) 2011-06-08
JP2005511075A (ja) 2005-04-28
HU228584B1 (en) 2013-04-29
NZ533256A (en) 2008-06-30
CA2784260A1 (en) 2003-06-19
DK1487483T3 (da) 2011-02-21
EP2263690A2 (en) 2010-12-22
ATE487490T1 (de) 2010-11-15
AU2008202333A1 (en) 2008-06-19
US7276353B2 (en) 2007-10-02
AU2011200843B2 (en) 2012-01-19
PT2264050T (pt) 2018-11-21
CY2011004I2 (el) 2015-10-07
SI2264050T1 (sl) 2018-12-31
CN103536911B (zh) 2019-09-13
HRP20140002A2 (hr) 2014-11-07
EP2264050A3 (en) 2011-04-20
CY2011004I1 (el) 2014-04-09
AU2002362147C1 (en) 2012-05-17
CA2469599A1 (en) 2003-06-19
JP4623964B2 (ja) 2011-02-02
RS51288B (sr) 2010-12-31
AU2011200843A1 (en) 2011-03-17
HRP20140003A2 (hr) 2014-11-07
HU231018B1 (hu) 2019-11-28
ES2529726T3 (es) 2015-02-25
DK2263689T3 (en) 2015-02-02
EP2263689A2 (en) 2010-12-22
LT2264050T (lt) 2018-11-26
FR11C0014I1 (cg-RX-API-DMAC7.html) 2011-06-17
RS51704A (sr) 2006-10-27
CY1111167T1 (el) 2014-04-09
MEP17708A (bs) 2010-06-10
DK2264050T3 (en) 2018-12-03
EP2263689A3 (en) 2011-04-20
US20030170270A1 (en) 2003-09-11
EP3388515A1 (en) 2018-10-17
TWI314580B (en) 2009-09-11
HU231162B1 (hu) 2021-05-28
CO5590938A2 (es) 2005-12-30
BR0214919A (pt) 2006-05-30
PL215058B1 (pl) 2013-10-31
CN1620310A (zh) 2005-05-25
AU2008202333B2 (en) 2010-11-25
HU230576B1 (hu) 2017-01-30
NL300480I2 (cg-RX-API-DMAC7.html) 2016-11-01
HRP20140003B1 (hr) 2020-10-16
HRP20140002B1 (hr) 2020-10-16
PT1487483E (pt) 2011-02-10
BRPI0214919B1 (pt) 2015-09-15
HUS2100036I1 (hu) 2021-09-28
SI1487483T1 (sl) 2011-03-31
HRP20040626B1 (hr) 2016-08-26
AU2002362147B2 (en) 2008-03-13
CN1620310B (zh) 2014-11-26
ME00126B (me) 2010-10-10
HK1151988A1 (en) 2012-02-17
EP1487483A4 (en) 2006-02-15
LU91814I2 (fr) 2011-07-04
PL395509A1 (pl) 2011-12-19
PT2263689E (pt) 2015-02-13
HRP20040626B9 (hr) 2016-09-23
KR20040086243A (ko) 2004-10-08
CY1121112T1 (el) 2019-12-11
DE60238278D1 (de) 2010-12-23
ES2355814T3 (es) 2011-03-31
EP2264050A2 (en) 2010-12-22
EP2263689B1 (en) 2014-11-12
AU2002362147A1 (en) 2003-06-23
PL374382A1 (en) 2005-10-17
EP1487483A2 (en) 2004-12-22
SI2263689T1 (sl) 2015-03-31

Similar Documents

Publication Publication Date Title
US10507238B2 (en) Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CA2784260C (en) Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
HK1151465A (en) Chimeric infectious dna clones of porcine circovirus and uses thereof
HK1151539A (en) Chimeric infectious dna clones of porcine circovirus and uses thereof
HK1151988B (en) Chimeric infectious dna clones of porcine circovirus and uses thereof
HK1151539B (en) Chimeric infectious dna clones of porcine circovirus and uses thereof
AU2012202224A1 (en) Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
ZA200404483B (en) Chimeric infectious dna clones chimeric porcine circoviruses and uses thereof

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20221212